EP0062

· Ellipses Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EP0062, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer [Phase 1, Phase 2]

See pricing